Franklin Resources
ATOS icon

Franklin Resources’s Atossa Therapeutics ATOS Stock Holding History

Franklin Resources’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,203
Closed -$52K – 2314
2022
Q2 		$52K Sell
3,203
-1,549
-33% -$24.4K ﹤0.01% 2238
2022
Q1 		$89K Buy
+4,752
New +$96.5K ﹤0.01% 2313
2021
Q4 		– Sell
-953
Closed -$47K – 2474
2021
Q3 		$47K Buy
+953
New +$55.4K ﹤0.01% 2382

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Franklin Resources's ATOS Position: Q3 2022 in Review

Franklin Resources sold out of Atossa Therapeutics (ATOS) in Q3 2022, closing a stake of 3,203 shares — an estimated $52K sold.

Franklin Resources first reported a position in ATOS in Q3 2021 and held it in 3 quarters. The position peaked at $89K in Q1 2022. 56 funds tracked by Wall St. Rank hold ATOS as of Q3 2022.

  • Franklin Resources reported no remaining Atossa Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Franklin Resources sold 3,203 Atossa Therapeutics shares in Q3 2022, an estimated $52K.
  • Franklin Resources first reported a position in Atossa Therapeutics in Q3 2021 and held it in 3 quarters.
  • Franklin Resources's Atossa Therapeutics position peaked at $89K in Q1 2022.
  • 56 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2022.

Based on Franklin Resources's 13F filing for Q3 2022, filed 14 Nov 2022.